PATENT CLAIM ANALYSIS

Application Number: 15893550
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "465000"]

Abstract:
In one aspect, pharmaceutical compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises digitally inserting into the lower third of the vagina of a subject having VVA a soft gelatin capsule containing a liquid pharmaceutical composition.

Claim (Index 1):
A method for treating vulvovaginal atrophy (VVA) in a subject, the method comprising: digitally inserting into the lower third of the vagina of the subject a soft gelatin capsule containing a liquid pharmaceutical composition, wherein the composition comprises estrogen and an excipient that increases the viscosity of the composition, and wherein the composition spreads over the vaginal tissue and is absorbed by the vaginal tissue with no vaginal discharge of the composition.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 88.0
- Lexical Diversity: 1.34211
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14521230', '14624051', '15893542', '15372385', '15893546']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8127833806401178
- 35 USC 102 Novelty (BERT): 0.5669514318698932
- Combined Prediction Score: 0.7882001857630954
- Mean Citation Score: 491.689274
- Max Citation Score: 529.34204
- Similarity Product: 381.4952441949606

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test